Profile
Nicholas Adams worked as Vice President-Business Development at Antisoma Research Ltd.
from 1999 to 2011.
He then worked as Chief Business Officer at Weifa ASA. From 2015 to 2018, he served as Chief Business Officer at Redx Pharma Plc.
In 2019, he worked as VP-Business Development & Alliance Management at ReNeuron Group Plc.
He also worked as Vice President-Business Development at Sarossa Capital Ltd.
Mr. Adams completed his undergraduate degree at the University of Hertfordshire and his graduate degree at The University of Law Ltd.
Former positions of Nicholas Adams
| Companies | Position | End |
|---|---|---|
| RENEURON GROUP PLC | Corporate Officer/Principal | 2020-07-31 |
| REDX PHARMA PLC | Corporate Officer/Principal | 2018-09-30 |
| Antisoma Research Ltd. | Corporate Officer/Principal | 2011-02-28 |
| WEIFA ASA | Corporate Officer/Principal | - |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Training of Nicholas Adams
| The University of Law Ltd. | Graduate Degree |
| University of Hertfordshire | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| REDX PHARMA PLC | Health Technology |
| RENEURON GROUP PLC | Health Technology |
| Private companies | 3 |
|---|---|
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Sarossa Capital Ltd. is an investment holding and management company. Its principal activity is investing in and growth and development of businesses which present opportunities for value creations. The company currently intends to indentify investment opportunities offering the potential to deliver a favorable return to shareholders over the medium term, primarily in the form of capital gain. The company was founded in 1988 and is headquartered in London, the United Kingdom. | Finance |
Weifa ASA
 Weifa ASA Pharmaceuticals: MajorHealth Technology Weifa ASA engages in the development, production and sales of medicines and other health products. Its products include medicines for pain relief, cough and cold, nutraceuticals, and dermatology. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |
| Antisoma Research Ltd. |
- Stock Market
- Insiders
- Nicholas Adams
